Gamida Cell Ltd. logoGamida Cell (NASDAQ:GMDA – Free Report) had its price objective reduced by Piper Sandler from $5.00 to $2.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have an overweight rating on the stock.
GMDA has been the topic of a number of other reports. JMP Securities restated a market outperform rating and issued a $6.00 price target on shares of Gamida Cell in a research report on Thursday, September 28th. Needham & Company LLC reiterated a buy rating and set a $6.00 target price on shares of Gamida Cell in a research report on Tuesday, August 15th. Finally, HC Wainwright reduced their target price on shares of Gamida Cell from $11.00 to $5.00 and set a buy rating on the stock in a research report on Wednesday. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of Buy and a consensus price target of $5.40.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.